Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06558253 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 18, 2024 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date changed from estimate of Nov 1, 2024 to Nov 29, 2024v3
  2. Start date: Sep 1, 2024 to Nov 1, 2024
    • Primary completion date: Dec 1, 2025 to Apr 1, 2026
    • Study completion date: Jun 1, 2026 to Sep 30, 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the safety and efficacy of coenzyme I for injection in promoting hematopoietic recovery after single-unit unrelated cord blood transplantation in hematological malignancies.
Trial Details
NCT Number NCT06558253
Lead Sponsor Anhui Provincial Hospital
Conditions
(from sponsor)		 Hematopoietic Recovery
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov